Categories AlphaGraphs, Earnings, Technology
Infographic: CrowdStrike (CRWD) Q1 earnings, revenues top expectations
Cybersecurity company CrowdStrike Holdings, Inc. (NASDAQ: CRWD) Thursday reported higher earnings and revenues for the first quarter of 2023 as demand conditions remained favorable due to strong digital transformation and cloud adoption. The results also beat the estimates.
First-quarter net income, excluding special items, rose to $0.31 per share from $0.10 per share a year earlier, surpassing the consensus forecast. On an unadjusted basis, it was a net loss of $31.5 million or $0.14 per share, compared to a loss of $85.0 million or $0.38 per share in the first quarter of 2022.
The positive earnings performance, on an adjusted basis, reflects a 61% increase in first-quarter revenues to $487.8 million, which also came in above the market’s prediction.
Check this space to read management/analysts’ comments on CrowdStrike’s Q1 earnings
Shares of CrowdStrike declined during Thursday’s extended trading, after closing the regular session higher.
_________________________________________________________________________________________________________________
Stocks you may like:
International Business Machines Corp. (IBM) Stock
_________________________________________________________________________________________________________________
Most Popular
Earnings Preview: UnitedHealth looks poised to end FY24 on a positive note
UnitedHealth Group (NYSE: UNH), a leading provider of health insurance and healthcare services, is expected to report fourth-quarter earnings next week. The company, a market leader in the nation's colossal
Mattel (MAT): A look at the toymaker’s evolving strategy and its opportunities
Shares of Mattel, Inc. (NASDAQ: MAT) stayed green on Wednesday. The stock has dropped 4% over the past month. Over the past few years, the toymaker has been focused on
AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8%
AngioDynamics Inc. (NASDAQ: ANGO) reported a net loss for the second quarter of 2025 as the medical device company’s revenues decreased 8%. Net loss, excluding special items, was $0.04 per
